Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2004 Sep;57(9):897-902.
doi: 10.1136/jcp.2003.010983.

Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment

I O Ellis  1 , S Humphreys, M Michell, S E Pinder, C A Wells, H D Zakhour; UK National Coordinating Commmittee for Breast Screening Pathology; European Commission Working Group on Breast Screening Pathology
Affiliations
Guideline

Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment

I O Ellis et al. J Clin Pathol. 2004 Sep.

Abstract

Non-operative diagnosis has become the norm in breast disease assessment and, until relatively recently, fine needle aspiration cytology has been the sampling method of choice. The introduction of automated core biopsy guns in the mid 1990s led to the additional introduction of core biopsy in assessment units. This paper presents a summary of the guidance on handling and routine reporting of breast needle core biopsy specimens in the context of breast disease multidisciplinary assessment. This guidance has been produced by the UK National Coordinating Committee for Breast Screening Pathology and is endorsed by the European Commission working group on breast screening pathology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Epithelial proliferative lesion classification. ADH, atypical ductal hyperplasia; DCIS, ductal carcinoma in situ.
Figure 2
Figure 2
Papillary lesion classification. DCIS, ductal carcinoma in situ.
See this image and copyright information in PMC

References

    1. Cytology sub-group of the National Coordinating Committee for Breast Cancer Screening Pathology. Guidelines for cytology procedures and reporting in breast cancer screening. NHSBSP publication number 22. Sheffield: NHS Breast Screening Programme, 1993.
    1. European Commission. European guidelines for quality assurance in mammography screening. de Wolf CJM, Perry NM, eds, 2nd ed. Luxembourg: Office for Official Publications of the European Communities, 1996.
    1. Non operative diagnosis subgroup of the National Coordinating Committee for Breast Screening Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. NHSBSP publication number 50. Sheffield, NHS Breast Screening Programme Publications, 2001 (pdf available from http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp50.pdf).
    1. Lamb J, Anderson TJ, Dixon MJ, et al. Role of fine needle aspiration cytology in breast cancer screening. J Clin Pathol 1987;40:705–9. - PMC - PubMed
    1. Zajdela A, Chossein NA, Pillerton JP. The value of aspiration cytology in the diagnosis of breast cancer. Cancer 1975;35:499–506. - PubMed